6. 6) skal infusionen indgives over cirka 1 time, og patienterne skal observeres under infusionen og i 1 time, efter at infusionen er tilendebragt for tegn og symptomer på overfølsomhedsreaktioner.
After dilution (see section 6.6), the infusion is to be administered over approximately 1 hour and patients are to be observed during the infusion and for 1 hour after the completion of the infusion for signs and symptoms of hypersensitivity reactions.